Neha Basheer

@niu.sav.sk

Postdoctoral researcher
Institute of neuroimmunology, Slovak Academy of Sciences

EDUCATION

B.Sc. (Hons.) Botany, Gargi College, Delhi University , New Delhi, India
September 2010 — August 2013

B.Ed. , Guru Gobind Singh Indraprastha University , New Delhi, India
September 2013 — August 2014

M.Sc. Biotechnology , Jamia Millia Islamia, New Delhi, India
September 2014 — August 2016

PhD, Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava, Slovakia
September 2019 — August 2023
Dissertation thesis titled: "Molecular modifiers of tau spreading - Inflammation, Phosphorylation and Mitochondria"

RESEARCH, TEACHING, or OTHER INTERESTS

Neuroscience, Molecular Biology, Immunology and Microbiology, Cellular and Molecular Neuroscience

149

Scholar Citations

Scholar h-index

Scholar i10-index

RECENT SCHOLAR PUBLICATIONS

Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models
N Basheer, L Buee, JP Brion, T Smolek, MK Muhammadi, J Hritz, ...
Acta neuropathologica communications 12 (1), 52 2024

AD-TAU INDUCED TANGLE-LIKE PATHOLOGY IN A NEWLY CHARACTERIZED TRANSGENIC MOUSE MODEL
MK Muhammadi, T Smolek, I Uhrinova, N Basheer, N Zilka
IBRO Neuroscience Reports 15, S283-S284 2023

Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer’s disease? From preclinical studies to the clinical trials
N Basheer, T Smolek, I Hassan, F Liu, K Iqbal, N Zilka, P Novak
Molecular psychiatry 28 (6), 2197-2214 2023

Enriched environment ameliorates propagation of tau pathology and improves cognition in rat model of tauopathy
V Mate, T Smolek, ZV Kazmerova, S Jadhav, V Brezovakova, B Jurkanin, ...
Frontiers in Aging Neuroscience 14, 935973 2022

Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
B Kovacech, L Fialova, P Filipcik, R Skrabana, M Zilkova, ...
EBioMedicine 76 2022

Second-Generation Antibodies Neutralize Emerging SARS-CoV-2 Variants of Concern
B Kovacech, L Fialova, P Filipcik, R Skrabana, M Zilkova, ...
bioRxiv, 2021.06. 09.447527 2021

Polo-like Kinase 1 as an emerging drug target: structure, function and therapeutic implications
I Shakeel, N Basheer, GM Hasan, M Afzal, MI Hassan
Journal of Drug Targeting 29 (2), 168-184 2021

Fibroblast growth factor receptor influences primary cilium length through an interaction with intestinal cell kinase
M Kunova Bosakova, A Nita, T Gregor, M Varecha, I Gudernova, B Fafilek, ...
Proceedings of the National Academy of Sciences 116 (10), 4316-4325 2019

TLR4-mediated chronic neuroinflammation has no effect on tangle pathology in a tauopathy mouse model
N Basheer, MK Muhammadi, CL Freites, M Avila, MU Momand, ...
Frontiers in Aging Neuroscience 16, 1468602

MOST CITED SCHOLAR PUBLICATIONS

Polo-like Kinase 1 as an emerging drug target: structure, function and therapeutic implications
I Shakeel, N Basheer, GM Hasan, M Afzal, MI Hassan
Journal of Drug Targeting 29 (2), 168-184 2021
Citations: 50